Diamedica Therapeutics Inc (DMAC)

08:15 AM

Diamedica Stock Soars 10.2% on Major Shareholder's Purchase - AInvest

08:15 AM

07:38 AM

Is this a good reentry point in DiaMedica Therapeutics Inc.Deep Stock Performance and Volatility Analysis - Newser

07:38 AM

07:36 AM

What’s the recovery path for long term holders of DiaMedica Therapeutics Inc.Equity Forecast with Predictive AI Screener - Newser

07:36 AM

06:54 AM

Can trapped investors hope for a rebound in DiaMedica Therapeutics Inc.ROI Focused Setup With Drawdown Analysis - Newser

06:54 AM

06:09 AM

Multi factor analysis applied to DiaMedica Therapeutics Inc.AI-Powered Stock Trend Movement Analysis - Newser

06:09 AM

05:13 AM

Analyzing DiaMedica Therapeutics Inc. with risk reward ratio charts Intraday Price Action Forecast Planner - Newser

05:13 AM

04:20 AM

What is the risk reward ratio of investing in DiaMedica Therapeutics Inc. stockBuild wealth with high-performing stocks - jammulinksnews.com

04:20 AM

01:26 AM

What are the latest earnings results for DiaMedica Therapeutics Inc.Explosive trading opportunities - jammulinksnews.com

01:26 AM

Jul 27, 2025

What are analysts’ price targets for DiaMedica Therapeutics Inc. in the next 12 monthsOutstanding investment returns - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What are the technical indicators suggesting about DiaMedica Therapeutics Inc.Rapid growth opportunities - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

How does DiaMedica Therapeutics Inc. compare to its industry peersLightning-fast growth - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedSafer Investing With Bigger Upside - Newser

Jul 27, 2025

Jul 27, 2025

What makes DiaMedica Therapeutics Inc. stock price move sharplyBreakout Setup Scanner - Newser

Jul 27, 2025

Jul 27, 2025

Is DiaMedica Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Stock Market Return Analysis - Newser

Jul 27, 2025

Jul 26, 2025

DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares By Investing.com - Investing.com South Africa

Jul 26, 2025

Jul 26, 2025

DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares - Investing.com

Jul 26, 2025

Jul 26, 2025

DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock - Investing.com

Jul 26, 2025

Jul 26, 2025

DiaMedica Therapeutics Stock (DMAC) Opinions on $30 Million Private Placement - Quiver Quantitative

Jul 26, 2025

Jul 25, 2025

What drives DiaMedica Therapeutics Inc. stock priceRapidly growing investment returns - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Ischemic Stroke Pipeline Experiences Rapid Expansion as Over 50+ Leading Companies Advance Novel Therapies - The Globe and Mail

Jul 25, 2025

Jul 25, 2025

DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia - MSN

Jul 25, 2025

Jul 25, 2025

DiaMedica Therapeutics Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is DiaMedica Therapeutics Inc. a good long term investmentMarket-crushing stock picks - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is DiaMedica Therapeutics Inc. stock overhyped or has real potentialBreakthrough financial growth - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

DiaMedica raises $30.1M in private placement for preeclampsia, stroke treatment - The Business Journals

Jul 24, 2025

Jul 24, 2025

The Beat: Entrust names new CEO, DiaMedica raises millions - The Business Journals

Jul 24, 2025

Jul 24, 2025

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement - BioSpace

Jul 24, 2025

Jul 23, 2025

DiaMedica Therapeutics Secures $30.1 Million in Private Placement - TipRanks

Jul 23, 2025

Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement By Investing.com - Investing.com Nigeria

Jul 23, 2025

Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement - Investing.com India

Jul 23, 2025

Jul 22, 2025

What analysts say about DiaMedica Therapeutics Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Diamedica Therapeutics shares rise 11.01% intraday after $30.1M private placement and positive trial results for DM199 in preeclampsia. - AInvest

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics to sell 8.606M shares at $3.50 in private placement - TipRanks

Jul 21, 2025

Jul 21, 2025

DiaMedica Announces $30.1M Private Placement for DM199 - TipRanks

Jul 21, 2025

Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials - Investing.com Australia

Jul 21, 2025

Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials By Investing.com - Investing.com India

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline - Business Wire

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Given New $11.00 Price Target at Craig Hallum - MarketBeat

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $12.00 - Defense World

Jul 21, 2025

Jul 20, 2025

DiaMedica shares drop 35% following InvestingPro’s overvalued warning By Investing.com - Investing.com India

Jul 20, 2025